Cardiovascular Clinical Studies

This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.

Feinstein Institutes’ Dr. Stavros Zanos is the senior author on the new bioelectronic medicine ultrasound paper

News | Hypertension

Ultrasound Neuromodulation Shows Promise to Treat Pulmonary Hypertension, Feinstein Institutes Research

May 8, 2024 — Ultrasound could one day complement or even replace drugs to treat diseases. Bioelectronic medicine ...

May 08, 2024

Medtronic released clinical outcomes in two transcatheter valve therapies from studies presented at the recent Society for Cardiovascular Angiography & Interventions 2024 Scientific Sessions, SCAI 2024.

News | SCAI

Medtronic TAVR Outcomes from SMART Trial and Optimize PRO Addendum on Evolut TAVR Presented at SCAI 2024 Scientific Sessions

May 7, 2024 — Medtronic announced the release of important clinical outcomes in two leading transcatheter valve ...

May 07, 2024

Reprieve Cardiovascular partners with leading heart failure researchers and Truveta to analyze real-world heart failure patient data to highlight opportunities to improve the current patient management paradigm

News | Cardiovascular Clinical Studies

New Study Published in JACC: Heart Failure Reveals that Despite Significant Efforts to Improve Acute Heart Failure Treatment Over the Past 20 Years, Management Remains Unchanged

May 2, 2024 — Reprieve Cardiovascular, Inc. (‘Reprieve’), a development stage company focused on pioneering an ...

May 02, 2024

The primary endpoint results of the open label roll-in cohort of the CardiAMP Cell Therapy in Chronic Myocardial Ischemia Trial

News | Cardiovascular Clinical Studies

BioCardia’s CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial Results Show Patient Benefits in Important Outcomes

May 2, 2024 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular ...

May 02, 2024

A study in more than 3,000 US counties, with 315 million residents, has suggested that air pollution is linked with stress and depression

News | Cardiovascular Clinical Studies

Air Pollution and Depression Linked with Heart Disease Deaths in Middle-aged Adults

May 1, 2024 — A study in more than 3,000 US counties, with 315 million residents, has suggested that air pollution is ...

May 01, 2024

News | Computed Tomography (CT)

Fully-automated One-click On-site CT-FFR: a Novel Tool for Functional Evaluation for Patients with Coronary Artery Disease

May 1, 2024 —In this 3-stage study, 3 cohorts were used for diagnostic performance, and prognostic performance ...

May 01, 2024

A multicenter study led by Vanderbilt University Medical Center (VUMC) and Lipscomb University College of Pharmacy in Nashville has identified a potential new treatment for acute heart failure, a leading cause of hospitalization and death

News | Heart Failure

Advance in the Treatment of Acute Heart Failure Identified

April 30, 2024 — A multicenter study led by Vanderbilt University Medical Center (VUMC) and Lipscomb University College ...

April 30, 2024

Researchers showcase an innovative strategy for regenerative heart therapy in a primate model, paving the way to clinical trials

News | Cardiovascular Clinical Studies

Using Stem Cell-derived Heart Muscle Cells to Advance Heart Regenerative Therapy

April 30, 2024 — Regenerative heart therapies involve transplanting cardiac muscle cells into damaged areas of the heart ...

April 30, 2024

Women with heart disease are less often treated with cholesterol-lowering drugs than men, according to research presented today at ESC Preventive Cardiology 2024, a scientific congress of the European Society of Cardiology (ESC)

News | Womens Cardiovascular Health

Women with Heart Disease Less Likely to Receive Life-saving Drugs than Men

April 29, 2024 — Women with heart disease are less often treated with cholesterol-lowering drugs than men, according to ...

April 29, 2024

New study shows an overwhelming majority of people aged 65 and over reduced their blood pressure, cholesterol, and weight while using the Hello Heart mobile app and heart health monitor within six months

News | Cardiovascular Clinical Studies

New Study Reveals 65 and Older Population Lowered Blood Pressure, Cholesterol and Weight Using Mobile Technology

April 24, 2024 —Hello Heart, a digital leader in preventive heart health, today announced results from its latest study ...

April 24, 2024

Second major trial for atrial shunt therapy demonstrates importance of patient selection

News | Cardiovascular Clinical Studies

Corvia's RESPONDER-HF Confirmatory Trial Supported by RELIEVE-HF Data

April 22, 2024 — Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, welcomes the ...

April 22, 2024

New evidence published in Heart Rhythm underpins why the blanking period should be shortened

News | Atrial Fibrillation

Shorten the Blanking Period After Atrial Fibrillation Ablation, Experts Say

April 18, 2024 — New evidence-based research calls into question the conventional three-month blanking period ...

April 18, 2024

AB-1002 is being studied for the treatment of adults with non-ischemic cardiomyopathy and New York Heart Association (NYHA) Class III heart failure symptoms

News | FDA

AskBio Receives FDA Fast Track Designation for AB-1002 Investigational Gene Therapy Program in Congestive Heart Failure

April 18, 2024 — Bayer AG and Asklepios BioPharmaceutical, Inc., a gene therapy company wholly owned and independently ...

April 18, 2024

News | Heart Valve Technology

CPR-Therapeutics, Inc. Names Mike Black as Chief Strategy Officer

April 17, 2024 —CPR Therapeutics, Inc. (CPR-T), an early-stage medtech startup funded by the N.I.H and N.S.F to develop ...

April 17, 2024

Investigational technology designed for patients undergoing emerging large bore percutaneous catheter-based venous interventional procedures

News | Cardiovascular Clinical Studies

CVRx Announces Availability of Additional Data Supporting Long-term Benefits of Barostim

April 16, 2024 — CVRx, Inc., a commercial-stage medical device company, announced today the availability of additional ...

April 16, 2024